MISAA

MISAA

Early Stage

15-min blood test

15-min blood test

Overview

Raised to Date: Raised: $1,009

Total Commitments ($USD)

Platform

Netcapital

Start Date

01/18/2024

Close Date

03/28/2024

Min. Goal
$10,000
Max. Goal
$1,000,000
Min. Investment

$99

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.00

Pre-Money Valuation

$10,000,000

Rolling Commitments ($USD)

Status

Active

Reporting Date

02/29/2024

Days Remaining

28

% of Min. Goal

10%

% of Max. Goal

0%

Likelihood of Max
unlikely
Avg. Daily Raise

$24

Momentum
cold.svg
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2023

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B2C

Margin

Medium

Capital Intensity

High

Location

Torrance, California

Business Type

Growth

MISAA, with a valuation of $10 million, is raising funds on NetCapital. The company is developing a 15-minute blood test for tacrolimus, required for organ transplant patients. MISAA’s TAC Assay will be a rapid test that will be usable in labs, POC, and homes and could enhance transplant outcomes for patients. The rapid test is also expected to impact the lives of recipients, caregivers, and service providers. Reuben Sandler founded MISAA in July 2023. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1 million. The campaign proceeds will be used for labor, clinical trials, product development, materials, consulting, admin, and overhead.

Summary Profit and Loss Statement

FY 2022 FY 2021

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$0

$0

Summary Balance Sheet

FY 2022 FY 2021

Cash

$0

$0

Accounts Receivable

$0

$0

Total Assets

$0

$0

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 01/18/2024
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
MISAA on NetCapital 2024
Platform: Netcapital
Security Type: Equity - Common
Valuation: $10,000,000
Price per Share: $1.00

Follow company

Follow MISAA on NetCapital 2024

Buy MISAA's Deal Report

MISAA Deal Report

Get KingsCrowd’s comprehensive report on MISAA including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether MISAA is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the MISAA deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge